Market Access in Emerging Markets

Enabling access to innovative drugs in emerging markets

A Kinapse White Paper
Written by Korina Papadopoulou & Pooja Sharma

Executive summary


Some countries with significant growth potential and commercial opportunities are accompanied by considerable challenges and risks. Global Pharma companies have invested substantially in emerging markets (EMs) to date with an aim to address rising unmet healthcare needs, backed by government willingness to implement healthcare reforms and increase public expenditure.

However, multifaceted market access challenges have contributed to the rising problem that is a lack of easy access to innovative drugs in EMs.

Kinapse, from extensive experience working in emerging markets, has developed a framework that assesses and prioritises potential solutions based on their expected business impact.

For more on this, as well as key considerations for designing and executing successful pricing and market access strategies, fill out the form above to download our latest white paper.

Download your copy

Fill out the form above to download this White Paper


Build trust among patients, healthcare professionals, payers and regulators
Patient safety is paramount


Ensure data quality
Increase regulatory & payer confidence in quality efficacy, safety and value claims


Decrease resources spent on rework and issue mitigation
Reduce efforts spent on fire-fighting


Avoid non-compliance with regulators and codes of conduct

One size doesn't fit all

Nulla dignissim lacus odio

At laoreet ante sollicitudin vel. Phasellus quam pellentesque id facilisis ut, fermentum at ipsum. Proin auctor efficitur vestibulum. Mauris commodo bibendum pulvinar.

Nulla dignissim lacus odio

At laoreet ante sollicitudin vel. Phasellus quam pellentesque id facilisis ut, fermentum at ipsum. Proin auctor efficitur vestibulum. Mauris commodo bibendum pulvinar.

Nulla dignissim lacus odio

At laoreet ante sollicitudin vel. Phasellus quam pellentesque id facilisis ut, fermentum at ipsum. Proin auctor efficitur vestibulum. Mauris commodo bibendum pulvinar.